European Society for Medical Oncology practice guidelines mandate histological diagnosis in all the patients and suggest the reporting of morphology, grading, and immunohistochemical staining of chromogranin A (cgA) and synaptophysin for appropriate pathological diagnosis of the tumor. This evidence concerns the gene CHGA and neoplasm.